Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial

Background: Angiotensin receptor blockers (ARBs), such as telmisartan, have been postulated to treat Covid-19-induced lung inflammation. Methods: This is a parallel-group, randomized, two-arm, open-label, adaptive, multicenter superiority trial with 1:1 allocation ratio. Participants included patien...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Mariano Duarte, Facundo Pelorosso, Liliana N. Nicolosi, M. Victoria Salgado, Héctor Vetulli, Analía Aquieri, Francisco Azzato, Marcela Castro, Javier Coyle, Ignacio Davolos, Ignacio Fernandez Criado, Rosana Gregori, Pedro Mastrodonato, María C. Rubio, Sergio Sarquis, Fernando Wahlmann, Rodolfo P. Rothlin
Format:	Artigo
Sprog:	Inglês
Udgivet:	Elsevier 2021-07-01
Serier:	EClinicalMedicine
Fag:	Covid-19 ARB Telmisartan ACE2
Online adgang:	http://www.sciencedirect.com/science/article/pii/S258953702100242X
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!